Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,316 | -4,190 | -3,426 | -1,545 | -4,239 |
| Accounts payable and accrued liabilities | -243 | 75 | 656 | 354 | 33 |
| Other Working Capital | -297 | -129 | 444 | 451 | 9 |
| Other Operating Activity | 1,062 | 739 | -638 | -344 | 80 |
| Operating Cash Flow | $-3,794 | $-3,505 | $-2,964 | $-1,084 | $-4,117 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | 1 | 1 | 1 | 87,362 |
| Common Stock Repurchased | -13,561 | -9,254 | -5,476 | -2,091 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -51 |
| Financing Cash Flow | $-13,560 | $-9,253 | $-5,475 | $-2,090 | $87,311 |
| Exchange Rate Effect | -7 | -2 | 1 | 1 | 5 |
| Beginning Cash Position | 85,401 | 85,401 | 85,401 | 85,401 | 2,202 |
| End Cash Position | 68,040 | 72,640 | 76,963 | 82,228 | 85,401 |
| Net Cash Flow | $-17,361 | $-12,760 | $-8,438 | $-3,173 | $83,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,794 | -3,505 | -2,964 | -1,084 | -4,117 |
| Free Cash Flow | -3,794 | -3,505 | -2,964 | -1,084 | -4,117 |